Japanese drugmaker Takeda has suffered a blow to its late-stage pipeline, after the FDA rejected its marketing application for TAK-721, a drug candidate that is trying to be the first approved therapy ...
Takeda Pharma less impacted by tariff, yen headwinds than others: CEO Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get ...
Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...
TAK is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of TAK shares has decreased $0.28 since the market last closed. This is a 1.55% ...
Products Market Alerts MyCollection Price Database Become a Partner Gallery ...
Surajkund Mela tragedy: Festival continues despite joyride that killed 1, 13 injured; ride area shut The 39th Surajkund International Crafts Festival will proceed as scheduled despite a fatal joyride ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Thanks for subscribing! Look out for your first newsletter in your inbox soon! The best of Hong Kong for free. Sign up for our email to enjoy Hong Kong without spending a thing (as well as some ...
Abstract: The “Every Soldier is a Sensor” (ES2) concept employs warfighters' proximity to unfolding events in order to provide better situational awareness and decision-making capabilities. However, ...
Linux or MacOS is recommended for development. If using Windows, replace "gradlew" with "gradlew.bat" in commands below. An x86-64 architecture CPU is required to build from source, including on MacOS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results